» Articles » PMID: 19415723

High Hyperdiploid Childhood Acute Lymphoblastic Leukemia

Overview
Date 2009 May 6
PMID 19415723
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

High hyperdiploidy (51-67 chromosomes) is the most common cytogenetic abnormality pattern in childhood B-cell precursor acute lymphoblastic leukemia (ALL), occurring in 25-30% of such cases. High hyperdiploid ALL is characterized cytogenetically by a nonrandom gain of chromosomes X, 4, 6, 10, 14, 17, 18, and 21 and clinically by a favorable prognosis. Despite the high frequency of this karyotypic subgroup, many questions remain regarding the epidemiology, etiology, presence of other genetic changes, the time and cell of origin, and the formation and pathogenetic consequences of high hyperdiploidy. However, during the last few years, several studies have addressed some of these important issues, and these, as well as previous reports on high hyperdiploid childhood ALL, are reviewed herein.

Citing Articles

Application of Omics Analyses in Pediatric B-Cell Acute Lymphoblastic Leukemia.

Vllahu M, Savarese M, Cantiello I, Munno C, Sarcina R, Stellato P Biomedicines. 2025; 13(2).

PMID: 40002837 PMC: 11852417. DOI: 10.3390/biomedicines13020424.


Imaging Flow Cytometric Identification of Chromosomal Defects in Paediatric Acute Lymphoblastic Leukaemia.

Simpson A, George C, Hui H, Doddi R, Kotecha R, Fuller K Cells. 2025; 14(2).

PMID: 39851542 PMC: 11763943. DOI: 10.3390/cells14020114.


V600E-Mutant Acute Myeloid Leukemia: A Case Series and Literature Review of a Rare Entity.

George G, Evans A, Jajosky A Genes (Basel). 2024; 15(11).

PMID: 39596583 PMC: 11593820. DOI: 10.3390/genes15111383.


Chromosomal instability: a key driver in glioma pathogenesis and progression.

Mazzoleni A, Awuah W, Sanker V, Bharadwaj H, Aderinto N, Tan J Eur J Med Res. 2024; 29(1):451.

PMID: 39227895 PMC: 11373396. DOI: 10.1186/s40001-024-02043-8.


Genomic Determinants of Outcome in Acute Lymphoblastic Leukemia.

Chang T, Chen W, Qu C, Cheng Z, Hedges D, Elsayed A J Clin Oncol. 2024; 42(29):3491-3503.

PMID: 39121442 PMC: 11458106. DOI: 10.1200/JCO.23.02238.